ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED
Get an alert when ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£66bn
USD 88,433,000,000
-6.4% vs 2024
Employees
0
Average over period
Profit before tax
£4.3bn
USD 5,822,000,000
-7.2% lowest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | £10,572,908,492 | £4,421,362,623 | £4,125,417,440 | -6.7% | |
| Profit before tax | £10,617,642,442 | £4,657,752,308 | £4,320,593,692 | -7.2% | |
| Net profit | £10,617,642,442 | £4,657,752,308 | £4,320,593,692 | -7.2% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | £70,129,735,753 | £65,627,458,256 | -6.4% | |
| Net assets | £38,074,085,701 | £70,129,735,753 | £65,627,458,256 | -6.4% | |
| Equity | £38,074,085,701 | £70,129,735,753 | £65,627,458,256 | -6.4% | |
| Average employees | — | 0 | 0 | — | |
| Wages | — | £0 | £0 | — | |
| Directors' remuneration | — | £0 | £0 | — |
Figures converted to GBP from USD at 0.742 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | — | 6.3% | 6.3% | |
| Gearing (liabilities / total assets) | 0.0% | 0.0% | 0.0% |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Based on their assessment of the Company's financial position, they continue to adopt the going concern basis in preparing the Financial Statements.”
Group structure
- ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED · parent
- AstraZeneca UK Limited 100%
- AstraZeneca S.A. 100%
- AstraZeneca Pty Limited 100%
- AstraZeneca Canada Inc. 100%
Significant events
- “In June 2024, the Company was served with a lawsuit filed by the University of Sheffield (Sheffield). In its complaint, Sheffield alleges that the Company made misrepresentations to induce Sheffield to amend a patent licence relating to Lynparza.”
- “In May 2026, a provision was recorded by a fellow AstraZeneca Group entity following a settlement being agreed. There is no financial impact on the Company.”
- “The Company received dividends from its subsidiary, AstraZeneca UK Limited, of $1,026m in January 2026, $812m in February 2026 and $1,080m in April 2026.”
- “In April 2026, the Company declared and paid up dividends to its parent company, AstraZeneca PLC, of $5,700m ($121,271 per share).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSTONE, Camilla | Secretary | 2025-05-01 | — | — |
| BOWDEN, Matthew Shaun | Director | 2025-05-01 | Dec 1977 | British |
| COLLINS, Iain Alistair | Director | 2017-05-31 | Dec 1970 | British |
| SARIN, Aradhana | Director | 2021-08-02 | Apr 1974 | American |
| SLADE, Jonathan Thomas Charles | Director | 2018-06-20 | Nov 1965 | British |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BOWDEN, Matthew Shaun | Secretary | 2019-02-27 | 2025-05-01 |
| HOSKINS, Justin Wilbert | Secretary | 2007-11-30 | 2011-12-16 |
| JACKSON-TURNER, Katie Louise | Secretary | 2015-07-15 | 2019-02-27 |
| O'GRADY, Claire-Marie | Secretary | 2011-12-16 | 2015-07-31 |
| SWIFT INCORPORATIONS LIMITED | Corporate Secretary | 2007-11-30 | 2007-11-30 |
| BOUCHER, Brendan James | Director | 2014-09-22 | 2017-12-31 |
| BRENNAN, David Richard | Director | 2007-11-30 | 2012-06-01 |
| BRIMICOMBE, Ian Martin David | Director | 2012-01-03 | 2017-05-31 |
| DARLINGTON, Keith Stuart | Director | 2012-10-31 | 2014-11-17 |
| DUNOYER, Marc Pierre Jean | Director | 2013-12-02 | 2021-08-02 |
| DUNOYER, Marc Pierre Jean | Director | 2013-11-01 | 2013-11-01 |
| GREENFIELD, Patricia May | Director | 2012-10-31 | 2014-10-17 |
| KEMP, Adrian Charles Noel | Director | 2015-12-01 | 2025-05-01 |
| KENYON, Paul | Director | 2007-11-30 | 2012-01-03 |
| LOWTH, Simon Jonathan | Director | 2007-11-30 | 2013-10-31 |
| INSTANT COMPANIES LIMITED | Corporate Director | 2007-11-30 | 2007-11-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Astrazeneca Plc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 109 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-11-27 RESOLUTIONS Resolution
- 2024-11-27 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-07 | AA | accounts | Accounts with accounts type full | |
| 2025-12-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-02 | AA | accounts | Accounts with accounts type full | |
| 2025-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-01 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2024-12-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-11-27 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-27 | MA | incorporation | Memorandum articles | |
| 2024-08-30 | SH01 | capital | Capital allotment shares | |
| 2024-08-28 | CH01 | officers | Change person director company with change date | |
| 2024-05-28 | AA | accounts | Accounts with accounts type full | |
| 2023-12-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-03 | AA | accounts | Accounts with accounts type full | |
| 2022-12-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-04 | AA | accounts | Accounts with accounts type full | |
| 2021-12-14 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-08-17 | AP01 | officers | Appoint person director company with name date | |
| 2021-08-05 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.